News & Views | Published:

Broad and strong: the ultimate antibody to dengue virus

Nature Immunology volume 16, pages 135137 (2015) | Download Citation

Subjects

The identification of a new class of cross-reactive monoclonal antibodies that strongly neutralize all four serotypes of dengue virus has important implications for vaccine design as well as for the evaluation of vaccines and of natural infection with dengue virus.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nat. Immunol. 16, 170–177 (2015).

  2. 2.

    & Curr. Opin. Virol. 2, 168–175 (2012).

  3. 3.

    et al. J. Virol. 87, 12562–12575 (2013).

  4. 4.

    et al. J. Virol. 86, 2665–2675 (2012).

  5. 5.

    et al. EMBO J. 28, 3269–3276 (2009).

  6. 6.

    et al. PLoS Negl. Trop. Dis. 5, e1188 (2011).

  7. 7.

    et al. Cell Host Microbe 8, 271–283 (2010).

  8. 8.

    et al. Science 328, 745–748 (2010).

  9. 9.

    et al. Proc. Natl. Acad. Sci. USA 109, 7439–7444 (2012).

  10. 10.

    et al. Sci. Transl. Med. 4, 139ra183 (2012).

  11. 11.

    et al. EMBO Mol. Med. 6, 358–371 (2013).

  12. 12.

    et al. J. Immunol. 189, 5877–5885 (2012).

  13. 13.

    et al. mBio 2013, 4, e00873–00813.

  14. 14.

    et al. J. Virol. 86, 4019–4023 (2012).

  15. 15.

    et al. PLoS Pathog. 9, e1003761 (2013).

Download references

Author information

Affiliations

  1. Josefina Coloma and Eva Harris are in the Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.

    • Josefina Coloma
    •  & Eva Harris

Authors

  1. Search for Josefina Coloma in:

  2. Search for Eva Harris in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Eva Harris.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ni.3081

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing